Nextar Chempharma Solutions
Contract Drug Development and Manufacturing
Startup Mature Health Tech & Life Sciences Est. 2007
Total Raised
$370K
Mature
Last Round
$370K
1 rounds
Team
3
11-50 employees
Confidence
90/100
News
4
articles
Patents
1
About
Nextar Chempharma Solutions specializes in the development of drugs and medical devices and manufacturing. Nextar's proprietary Brain Targeted Liposomes platform can facilitate targeted delivery of versatile drugs across the blood-brain barrier and into the brain. The drug delivery platform is a combination of a liposomal vehicle with the targeter complex that allows blood-brain barrier permeation and brain-specific delivery of versatile therapeutic agents.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
Biologicals
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business Model
B2B
Tags
cns-disordersgeneric-drugspharmaceuticalspharma-companiesdrug-delivery
Funding & Events
Jul 2022
Non-equity $370K
News (4)
Sep 19, 2023 ยท maya.tase.co.il
ื ืงืกื˜ืจ-ืชื•ืฆืื•ืช ืกื•ืคื™ื•ืช ื—ื™ื•ื‘ื™ื•ืช ืฉืœ ื ื™ืกื•ื™ ื‘ืขื›ื‘ืจื™ื ืœื”ื“ื’ืžืช ื™ืขื™ืœื•ืช ื˜ื™ืคื•ืœ ื‘ืกืจื˜ืŸ ืžื•ื— ืžืกื•ื’ ื’ืœื™ื•ื‘ืœืกื˜ื•ืžื” ื‘ื”ืชื‘ืกืก ืขืœ ืคืœื˜ืคื•ืจืžืช ื”-BTLS ืฉืœ ื”ื—ื‘'
Sep 18, 2023 ยท www.sponser.co.il
growth-positive
ื ืงืกื˜ื™ื™ื’' ื—ืชืžื” ืขืœ ื”ืกื›ื ืœืžื™ื–ื•ื’ ื ืงืกื˜ืจ ืœืคื™ ืฉื•ื•ื™ ืฉืœ ืœื ืคื—ื•ืช ืž-78 ืžื™ืœื™ื•ืŸ ืฉืงืœ
Acquired-by
Aug 4, 2019 ยท www.calcalistech.com
growth-positive
Cannabis Pharmaceutical Outfit Nextage Wants to Raise $15 Million in Canada
InvestmentAcquisition
Nov 9, 2017 ยท www.globes.co.il
growth-positive
Israel's Nextar setting up medical cannabis incubator
InvestmentPartners
Details
Product Stage
Released
Employees
11-50
Exact Count
27
District
Center District
Founded
2007
Registrar
514011113
Locations
Einstein 13, Ness Ziona, Israel
Links
Website
LinkedIn
Facebook
Admin
Last Update
Sep 14, 2024
Verified by
Natalia Golczar
Claimed
Yes
Missing
funding rounds, markets, not claimed
Team (3)
Orna Dreazen
Founder & CEO
Founder
Hilla Ben-David
CTO
Shlomit Kenigsberg
VP of Business Development
Internal
Created by
Jenny Sotnik-Talisman (genys30@yahoo.com)
Created
2017-11-12T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)